• Thu, November 11, 2021

Ed Arce Maintained (AKBA) at Strong Buy with Increased Target to $10 on, Nov 11th, 2021

Ed Arce of HC Wainwright & Co., Maintained "Akebia Therapeutics, Inc." (AKBA) at Strong Buy with Increased Target from $6 to $10 on, Nov 11th, 2021.

Ed, nor any peers, have made any analyst calls on AKBA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30